Jan Peter Rake

Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA

Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema

The glucose-6-phosphatase system

Lipid nanoparticles for mRNA delivery

Increased de novo Lipogenesis and Delayed Conversion of Large VLDL into Intermediate Density Lipoprotein Particles Contribute to Hyperlipidemia in Glycogen Storage Disease Type 1a

Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery

Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity

Delivery of mRNA Therapeutics for the Treatment of Hepatic Diseases

Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis

Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery

Update in global trends and aetiology of hepatocellular carcinoma

G6PC mRNA Therapy Positively Regulates Fasting Blood Glucose and Decreases Liver Abnormalities in a Mouse Model of Glycogen Storage Disease 1a

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

Granulocyte Colony–Stimulating Factor Mobilizes CD34+ Cells and Improves Survival of Patients With Acute-on-Chronic Liver Failure

Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis

Understanding the Intersections between Metabolism and Cancer Biology

Transient yet Robust Expression of Proteins in the Mouse Liver via Intravenous Injection of Lipid Nanoparticle-encapsulated Nucleoside-modified mRNA

Metabolic dysregulation in monogenic disorders and cancer — finding method in madness

The Severe Chronic Neutropenia International Registry: 10-Year Follow-up Report

Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors

Restoration of Motor Function through Delayed Intraspinal Delivery of Human IL-10-Encoding Nucleoside-Modified mRNA after Spinal Cord Injury

Fundamentals of cancer metabolism

Pathophysiology of Type 2 Diabetes Mellitus

Ionizable lipid nanoparticles for in utero mRNA delivery

Metabolic reprogramming and cancer progression

The Biochemistry and Molecular Biology of the Glucose-6-Phosphatase System¹

Human Fatty Liver Disease: Old Questions and New Insights

Chemistry and Biology Of Multicomponent Reactions

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

Granulocyte colony-stimulating factor in glycogen storage disease type 1b. Results of the European Study on Glycogen Storage Disease Type 1

Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I)

Guidelines for management of glycogen storage disease type I - European Study on Glycogen Storage Disease Type I (ESGSD I)

Glycogen storage disease type Ia: recent experience with mutation analysis, a summary of mutations reported in the literature and a newly developed diagnostic flowchart

Guidelines for management of glycogen storage disease type I—European study on glycogen storage disease type I (ESGSD I)

Apoptotic neutrophils in the circulation of patients with glycogen storage disease type 1b (GSD1b)

Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European study on glycogen storage disease type I (ESGSD I)